Biomarkers

Biomarkers still become progressively relevant in analysis and care applications, as proven by the worldwide marketplace for product concerned in their identification, validation, and use calculable at $8.3 billion in 2007 and projected to extend to $15 billion in 2010. AACR, in partnership with the Food and Drug Administration (FDA) and National Cancer Institute (NCI), shaped the AACR-FDA-NCI Cancer Biomarkers cooperative (CBC) to accelerate the interpretation of cancer medicine into the clinic by shaping the processes for the effective development of valid biomarkers and their use in clinical trials for optimum patient profit.

 

 

 

 

 

 

<p justify;"="">

    Related Conference of Biomarkers

    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    June 28-30 2020

    Stroke Summit 2020

    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    September 23-24, 2020

    24th European Biotechnology Congress

    Berlin, Germany
    October 19-20, 2020

    7th Asia Pacific Geriatrics and Gerontology Congress

    Tokyo, Japan
    October 23-24, 2020

    2nd International Conference on Biomarkers and Cancer Targets

    Cape Town, South Africa
    November 23-24, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 07- 08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 14-15, 2020

    New frontiers in Genetics Research & Advanced Techniques

    San Antonio, USA

    Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in